Jan J Stepan

Jan J Stepan

UNVERIFIED PROFILE

Are you Jan J Stepan?   Register this Author

Register author
Jan J Stepan

Jan J Stepan

Publications by authors named "Jan J Stepan"

Are you Jan J Stepan?   Register this Author

37Publications

747Reads

36Profile Views

Update on Menopausal Hormone Therapy for Fracture Prevention.

Curr Osteoporos Rep 2019 Nov 18. Epub 2019 Nov 18.

Institute of Microbiology of the Czech Academy of Sciences, v.v.i., Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11914-019-00549-3DOI Listing
November 2019

Secondary fracture prevention in hip fracture patients requires cooperation from general practitioners.

Arch Osteoporos 2017 May 18;12(1):49. Epub 2017 May 18.

Department of Orthopedics and Traumatology, Faculty Hospital Královské Vinohrady, Faculty of Medicine 3, Charles University, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11657-017-0346-zDOI Listing
May 2017

Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis.

BMC Musculoskelet Disord 2016 07 22;17:308. Epub 2016 Jul 22.

Institute of Rheumatology, Prague, and Faculty of Medicine 1, Charles University Prague, Na Slupi 4, Prague, CZ 12850, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12891-016-1168-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957857PMC
July 2016

Strontium ranelate: in search for the mechanism of action.

Authors:
Jan J Stepan

J Bone Miner Metab 2013 Nov 9;31(6):606-12. Epub 2013 Aug 9.

Institute of Rheumatology, and First Faculty of Medicine, Charles University, Na Slupi 4, 128 50, Prague 2, Czech Republic,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00774-013-0494-1
Publisher Site
http://dx.doi.org/10.1007/s00774-013-0494-1DOI Listing
November 2013

Bone status in adults with early-onset juvenile idiopathic arthritis following 1-year anti-TNFα therapy and discontinuation of glucocorticoids.

Rheumatol Int 2013 Aug 1;33(8):2001-7. Epub 2013 Feb 1.

Institute of Rheumatology, Na Slupi 4, 128 50 Prague 2, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-013-2678-3DOI Listing
August 2013

Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes.

Calcif Tissue Int 2013 Apr 18;92(4):354-61. Epub 2012 Dec 18.

Institute of Rheumatology, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00223-012-9684-4DOI Listing
April 2013

Secondary osteoporosis: endocrine and metabolic causes of bone mass deterioration.

J Osteoporos 2012 23;2012:907214. Epub 2012 Feb 23.

Department of Hypertension and Internal Medicine, Pomeranian Medical University, Szczecin, Poland.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/jos/2012/907214/
Publisher Site
http://dx.doi.org/10.1155/2012/907214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317090PMC
August 2012

Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence.

Eur J Endocrinol 2012 Jun 21;166(6):1003-11. Epub 2012 Mar 21.

Department of Obstetrics and Gynecology, Faculty of Medicine 1, Charles University, Prague, Czech Republic.

View Article

Download full-text PDF

Source
https://eje.bioscientifica.com/view/journals/eje/166/6/1003.
Publisher Site
http://dx.doi.org/10.1530/EJE-11-1047DOI Listing
June 2012

Hip fracture incidence from 1981 to 2009 in the Czech Republic as a basis of the country-specific FRAX model.

Calcif Tissue Int 2012 May 8;90(5):365-72. Epub 2012 Mar 8.

Institute of Rheumatology, Prague, and Department of Rheumatology, Charles University, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00223-012-9582-9DOI Listing
May 2012

A comparison of the acute effects of calcium and strontium ranelate on the serum marker of bone resorption.

Clin Chem Lab Med 2011 Nov 14;50(2):333-5. Epub 2011 Nov 14.

Institute of Rheumatology, Faculty of Medicine 1, Charles University, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/CCLM.2011.781DOI Listing
November 2011

The effect of timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal osteoporosis.

Eur J Endocrinol 2011 Apr 2;164(4):643-8. Epub 2011 Feb 2.

Department of Internal Medicine III-Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U Nemocnice 1, Cz-128 08 Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-10-1108DOI Listing
April 2011

Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate.

J Bone Miner Res 2009 Dec;24(12):1998-2006

Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1359/jbmr.090527DOI Listing
December 2009

Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.

Bone 2009 Apr 24;44(4):634-8. Epub 2008 Dec 24.

Department of Internal Medicine 3, Charles University, Faculty of Medicine, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S875632820800957
Publisher Site
http://dx.doi.org/10.1016/j.bone.2008.12.013DOI Listing
April 2009

Marker of Bone Resorption in Acute Response to Exogenous or Endogenous Parathyroid Hormone.

Biomark Insights 2008 Jan 25;3:19-24. Epub 2008 Jan 25.

3rd Department of Internal Medicine and Institute of Rheumatology, Charles University Faculty of Medicine, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688364PMC
January 2008

No associations between genetic polymorphisms of TGF-beta, PAI-1, and COL1A1, and bone mineral density in Caucasian females.

Endocr Regul 2006 Dec;40(4):107-12

Institute for Clincal and Experimental Medicine, Prague, Czech Republic.

View Article

Download full-text PDF

Source
December 2006

Genetic polymorphisms of TGF-beta, PAI-1, and COL1A-1, and determination of bone mineral density in Caucasian females.

Endocr Regul 2006 Sep;40(3):77-81

Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

View Article

Download full-text PDF

Source
September 2006

The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis.

J Clin Endocrinol Metab 2006 Mar 13;91(3):870-7. Epub 2005 Dec 13.

Third Department of Internal Medicine, Charles University, Faculty of Medicine, U Nemocnice 1, 128 00 Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2004-2212DOI Listing
March 2006

Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids.

Clin Chim Acta 2004 Oct;348(1-2):147-54

Department of Internal Medicine 3, Charles University Faculty of Medicine, U Nemocnice 1, CZ-128 00, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000989810400268
Publisher Site
http://dx.doi.org/10.1016/j.cccn.2004.05.012DOI Listing
October 2004

The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.

Clin Endocrinol (Oxf) 2004 Apr;60(4):442-50

Third Department of Internal Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2265.2004.02000.xDOI Listing
April 2004

Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.

Clin Endocrinol (Oxf) 2004 Mar;60(3):350-7

Third Department of Internal Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2265.2003.01987.xDOI Listing
March 2004

Calcitonin load test to assess the efficacy of salmon calcitonin.

Clin Chim Acta 2003 Oct;336(1-2):49-55

Department of Internal Medicine 3, Faculty of Medicine 1, Charles University, U nemocnice 1, CZ-128 00, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0009-8981(03)00332-2DOI Listing
October 2003

The effects of three-month intravenous ibandronate on bone mineral density and bone remodeling in Klinefelter's syndrome: the influence of vitamin D deficiency and hormonal status.

Bone 2003 Oct;33(4):589-96

3rd Department of Internal Medicine, Charles University School of Medicine, Faculty of Medicine, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s8756-3282(03)00205-9DOI Listing
October 2003

Plasma type 1 collagen cross-linked C-telopeptide: a sensitive marker of acute effects of salmon calcitonin on bone resorption.

Clin Chim Acta 2002 Feb;316(1-2):63-9

Department of Internal Medicine 3, Faculty of Medicine, Charles University, U nemocnice 1, 12800 Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0009-8981(01)00731-8DOI Listing
February 2002